Cargando…
Expanding and validating the biomarkers for mitochondrial diseases
ABSTRACT: Mitochondrial diseases are highly heterogeneous metabolic disorders caused by genetic alterations in the mitochondrial DNA (mtDNA) or in the nuclear genome. In this study, we investigated a panel of blood biomarkers in a cohort of 123 mitochondrial patients, with prominent neurological and...
Autores principales: | Maresca, Alessandra, Del Dotto, Valentina, Romagnoli, Martina, La Morgia, Chiara, Di Vito, Lidia, Capristo, Mariantonietta, Valentino, Maria Lucia, Carelli, Valerio |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7524861/ https://www.ncbi.nlm.nih.gov/pubmed/32851462 http://dx.doi.org/10.1007/s00109-020-01967-y |
Ejemplares similares
-
Rapamycin rescues mitochondrial dysfunction in cells carrying the m.8344A > G mutation in the mitochondrial tRNA(Lys)
por: Capristo, Mariantonietta, et al.
Publicado: (2022) -
The optic nerve: A “mito-window” on mitochondrial neurodegeneration
por: Maresca, Alessandra, et al.
Publicado: (2013) -
Calcium mishandling in absence of primary mitochondrial dysfunction drives cellular pathology in Wolfram Syndrome
por: La Morgia, Chiara, et al.
Publicado: (2020) -
Author Correction: Calcium mishandling in absence of primary mitochondrial dysfunction drives cellular pathology in Wolfram Syndrome
por: La Morgia, Chiara, et al.
Publicado: (2020) -
Peculiar combinations of individually non-pathogenic missense mitochondrial DNA variants cause low penetrance Leber’s hereditary optic neuropathy
por: Caporali, Leonardo, et al.
Publicado: (2018)